Navy Nexus

Shortly after the article that follows was drafted, I was notified that I had been nominated for promotion to vice admiral and assignment as Superintendent of the U.S. Naval Academy. This unexpected set of orders will cause me to depart the Naval War College after only one year as its President. Still, and although much remains to be done to keep the college at the top of its game, the organizational and administrative changes its faculty and staff have accomplished over the past twelve months have refined its educational and research programs in significant ways. The article (which collects and elaborates on material that, in some cases, has already appeared in print, including the “President’s Forums” of the Spring and Summer 2014 issues of the Review) serves as evidence of what dedicated professionals can do when motivated by an unrelenting commitment to excellence. If it’s important to the Navy, it is on the agenda at the Naval War College! This is a bold statement, but it is one that can be rather quickly substantiated by even a casual review of what is happening on the busiest educational and research complex in the Navy—the Newport, Rhode Island, campus of the U.S. Naval War College (NWC). Since 1884, the Naval War College has existed as a place to study conflict and to produce leaders who are critical thinkers. As it celebrates its 130th anniversary, the college continues to refine its educational and research programs to meet the demands of the Navy and the national security community. While some of our more traditional offerings, such as our highly regarded Joint Professional Military Education (JPME) programs, are fairly well-known, other programs and initiatives are regaining their intended direct linkage to and support to the fleet. The primary purpose of this article is to highlight the ways in which the Naval War College is helping to prepare and shape the Navy of Tomorrow and how it is significantly supporting the Navy of Today without forgetting the lessons of history

CASE STUDY: THE IBAR BRIDGE ATTACK

In 1999, I was the commanding officer of the VF-14 ‘Tophatters’, an F-14 squadron assigned to Carrier Air Wing Eight embarked in USS Theodore Roosevelt (CVN 71). We were flying F- 14A Tomcats, the oldest Tomcats in the fleet, modified for the air-to-ground mission with the Low Altitude Navigation and Targeting Infra-Red for Night (LANTIRN) system. Departing in late March 1999 for a planned six-month deployment, we made a quick transit across the Atlantic Ocean with orders to be prepared for action in the Balkans. On 6 April, our squadron conducted combat operations in support of Operation Allied Force (North Atlantic Treaty Organization (NATO) and Operation Noble Anvil (USA) in Kosovo. ... Having served 32 years in our navy, I am often asked to talk about combat operations. When I reflect on my life lessons, I often discuss the details of this one particular ‘bridge’ mission in Kosovo. I do not talk too much about targets that I or my fellow aviators successfully destroyed, but I do often reflect on this mission as one of my personal life-changing moments and how its positive impact influenced an entire squadron. I continue to think about its significance to this day

The Social Impact of Reservoir Construction on a Rural Community: A Synthesis of a Ten Year Research Project

Exact date of working paper unknown

Beautiful Eyes

https://digitalcommons.library.umaine.edu/mmb-vp/1082/thumbnail.jp

A review of the pharmacology and clinical application of alfaxalone in cats

AbstractAlfaxalone-2-hydroxpropyl-β-cyclodextrin (alfaxalone-HPCD) was first marketed for veterinary use in Australia in 2001 and has since progressively became available throughout the world, including the USA, where in 2012 Food and Drug Administration (FDA) registration was granted. Despite the growing body of published works and increasing global availability of alfaxalone-HPCD, the accumulating evidence for its use in cats has not been thoroughly reviewed. The purpose of this review is: (1) to detail the pharmacokinetic properties of alfaxalone-HPCD in cats; (2) to assess the pharmacodynamic properties of alfaxalone-HPCD, including its cardiovascular, respiratory, central nervous system, neuromuscular, hepatic, renal, haematological, blood-biochemical, analgesic and endocrine effects; and (3) to consider the clinical application of alfaxalone-HPCD for sedation, induction and maintenance of anaesthesia in cats. Based on the published literature, alfaxalone-HPCD provides a good alternative to the existing intravenous anaesthetic options for healthy cats